What did @newyorkisntdead actually say?
Nothing about Wegovy. Seriously. The creator sang lyrics from Don McLean's "American Pie" — the Chevy, the levy, the whiskey, the boys. That's it. The caption reads "The Wegovy effect!!" but the video contains zero spoken claims about semaglutide, weight loss, GLP-1 receptors, or anything remotely medical. This fact-check has almost nothing to work with, and that's worth saying plainly.
The disconnect between caption and content is the whole story here. Millions of viewers saw a GLP-1-tagged video that delivered a classic rock singalong. Whether the creator meant to imply something about Wegovy's effects on mood, energy, or behavior, we can't know. They didn't say it. Speculation about what a caption implies is not the same as a health claim, and we're not going to treat it like one.
Does the science back this up?
There is no scientific claim in this video to evaluate. The lyrics to "American Pie" have not, to our knowledge, been published in a peer-reviewed journal on GLP-1 pharmacology. That said, the framing of the caption, "The Wegovy effect," does gesture toward a real and growing conversation about semaglutide's neurological and behavioral effects beyond weight loss.
Research is genuinely emerging on this. A 2023 paper by Blum et al. in Obesity Reviews examined preclinical and clinical evidence suggesting GLP-1 receptor agonists may influence reward pathways, mood, and even compulsive behaviors. A 2024 Nature Medicine study by Anekwe et al. noted patient-reported reductions in alcohol cravings and impulsive behavior on semaglutide. Whether someone singing old songs fits that pattern is, charitably, a stretch. But the underlying science is real, even if this video doesn't actually engage with it.
What did they get wrong (or right)?
They didn't get anything wrong, because they didn't say anything. That sounds like a pass, but it isn't. Tagging a video as GLP-1 content and captioning it "The Wegovy effect" while only singing a song creates implicit framing without any accountability. Viewers don't parse captions versus content the way a fact-checker does. For 2.3 million people, the association between Wegovy and whatever mood or behavior the video depicts gets planted without a single checkable claim.
This is a pattern worth naming. Anecdotal GLP-1 content on TikTok frequently operates through implication rather than assertion. A creator sings, dances, laughs, cries, and the caption does the medical work. That's harder to fact-check and potentially more persuasive than an explicit claim. The FDA has flagged social media health content as a growing regulatory concern precisely because implied endorsements and associations can shape patient behavior even without direct claims.
What should you actually know?
If the caption is pointing at something real, here's what the evidence actually says about behavioral and mood effects of semaglutide. The data is preliminary but interesting. GLP-1 receptors exist in the brain, not just the gut and pancreas. Animal studies have shown reduced alcohol consumption and lower impulsive food-seeking behavior. Human data is thinner but accumulating.
A 2023 randomized trial by Klausen et al. in JCI Insight found semaglutide reduced alcohol intake in patients with alcohol use disorder. A separate 2024 observational study in Nature Communications found lower rates of nicotine and opioid use among patients on GLP-1 agonists compared to matched controls. None of this means Wegovy fixes your relationship with whiskey or makes you want to sing Don McLean songs. It means the drug has neurological effects we don't fully understand yet, and that research is ongoing. Anyone experiencing unexpected mood or behavioral changes on a GLP-1 medication should talk to a clinician, not attribute it to a TikTok caption.